Vincent Milano

Director at Biocryst Pharmaceuticals · 7 reported transactions in 2 companies · latest report Jun 5, 2026

Their trades


Aclaris TherapeuticsACRS	Exercised options — · 11,580 shares	Jun 5, 2026
Biocryst PharmaceuticalsBCRX	Share award $7.4K · 848 shares	Feb 27, 2026
Biocryst PharmaceuticalsBCRX	Share award $5.6K · 783 shares	Nov 28, 2025
Biocryst PharmaceuticalsBCRX	Share award $5.6K · 676 shares	Aug 29, 2025
Biocryst PharmaceuticalsBCRX	Share award — · 12,500 shares	Jun 12, 2025
Aclaris TherapeuticsACRS	Exercised options — · 4,793 shares	Jun 6, 2025
Biocryst PharmaceuticalsBCRX	Share award $5.6K · 523 shares	May 30, 2025

Jun 5, 2026 · ACRS

11,580

Feb 27, 2026 · BCRX

$7.4K

Nov 28, 2025 · BCRX

$5.6K

Aug 29, 2025 · BCRX

$5.6K

Jun 12, 2025 · BCRX

12,500

Jun 6, 2025 · ACRS

4,793

May 30, 2025 · BCRX

$5.6K

7 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Director at Biocryst Pharmaceuticals · 7 reported transactions in 2 companies · latest report Jun 5, 2026


Aclaris TherapeuticsACRS	Exercised options — · 11,580 shares	Jun 5, 2026
Biocryst PharmaceuticalsBCRX	Share award $7.4K · 848 shares	Feb 27, 2026
Biocryst PharmaceuticalsBCRX	Share award $5.6K · 783 shares	Nov 28, 2025
Biocryst PharmaceuticalsBCRX	Share award $5.6K · 676 shares	Aug 29, 2025
Biocryst PharmaceuticalsBCRX	Share award — · 12,500 shares	Jun 12, 2025
Aclaris TherapeuticsACRS	Exercised options — · 4,793 shares	Jun 6, 2025
Biocryst PharmaceuticalsBCRX	Share award $5.6K · 523 shares	May 30, 2025